While histological subtyping is invaluable, it faces several challenges:
Inter-observer Variability: Different pathologists might interpret the same sample differently, leading to inconsistencies. Tumor Heterogeneity: Tumors can contain multiple subtypes, complicating diagnosis and treatment. Technological Limitations: While advances like digital pathology are promising, they are not yet universally accessible.
